\u0160odien, 27. novembr\u012b, akciju sabiedr\u012bbas Grindeks \u201eNasdaq Riga\u201d iesniegtie 2017. gada devi\u0146u m\u0113ne\u0161u nerevid\u0113tie konsolid\u0113tie finan\u0161u p\u0101rskati liecina, ka koncerna apgroz\u012bjums 2017. gada devi\u0146os m\u0113ne\u0161os bija 95,9 milj. eiro, kas ir par 23,5 milj. eiro vai par 32% vair\u0101k nek\u0101 2016. gada devi\u0146os m\u0113ne\u0161os. Savuk\u0101rt koncerna neto pe\u013c\u0146a, kas attiecin\u0101ma uz m\u0101tes sabiedr\u012bbas akcion\u0101riem, 2017. gada devi\u0146os m\u0113ne\u0161os bija 6,5 milj. eiro, kas, sal\u012bdzinot ar 2016. gada devi\u0146iem m\u0113ne\u0161iem, ir palielin\u0101jusies par 0,04 milj. eiro vai 1%.<\/p>\n\n\n\n
Bruto pe\u013c\u0146as rentabilit\u0101te 2017. gada devi\u0146os m\u0113ne\u0161os bija 58%, savuk\u0101rt t\u012br\u0101s pe\u013c\u0146as rentabilit\u0101te bija 7%. 2017. gada devi\u0146os m\u0113ne\u0161os Koncerna sara\u017eot\u0101 produkcija eksport\u0113ta uz 69 pasaules valst\u012bm kopum\u0101 par 88,8 milj. eiro, kas ir par 24,0 milj. eiro vai par 37% vair\u0101k nek\u0101 2016. gada devi\u0146os m\u0113ne\u0161os.<\/p>\n\n\n\n
Grindeks gatavo z\u0101\u013cu p\u0101rdo\u0161anas apjoms 2017. gada devi\u0146os m\u0113ne\u0161os bija 89,7 milj. eiro un ir palielin\u0101jies, sal\u012bdzinot 2016. gada devi\u0146iem m\u0113ne\u0161iem, par 23,8 milj. eiro vai 36%. P\u0101rdo\u0161anas apjoms Krievij\u0101, p\u0101r\u0113j\u0101s NVS valst\u012bs un Gruzij\u0101 2017. gada devi\u0146os m\u0113ne\u0161os sasniedza 58,9 milj. eiro, kas ir par 20,7 milj. eiro vai par 54% vair\u0101k nek\u0101 2016. gada devi\u0146os m\u0113ne\u0161os. Sal\u012bdzinot ar 2016. gada devi\u0146iem m\u0113ne\u0161iem, 2017. gada devi\u0146os m\u0113ne\u0161os, iev\u0113rojam\u0101kais p\u0101rdo\u0161anas apjoma pieaugums sasniegts \u2013 Tad\u017eikist\u0101n\u0101 2 reizes, Krievij\u0101 par 87%, Azerbaid\u017e\u0101n\u0101 par 40%, Kirgizst\u0101n\u0101 par 36%, Ukrain\u0101 par 28% un Arm\u0113nij\u0101 par 26%.<\/p>\n\n\n\n
P\u0101rdo\u0161anas apjoms Baltijas un cit\u0101s valst\u012bs 2017. gada devi\u0146os m\u0113ne\u0161os sasniedza 30,7 milj. eiro, kas ir par 3,1 milj. eiro vai 11% vair\u0101k nek\u0101 2016. gada devi\u0146os m\u0113ne\u0161os. P\u0101rdo\u0161anas apjoms 2017. gada devi\u0146os m\u0113ne\u0161os, sal\u012bdzinot ar 2016. gada devi\u0146iem m\u0113ne\u0161iem, Francij\u0101 ir palielin\u0101jies par 78%, \u010cehij\u0101 par 73%, Sp\u0101nij\u0101 par 52%, Vjetnam\u0101 par 47%. P\u0101rdo\u0161anas apjoms Latvij\u0101 2017. gada devi\u0146os m\u0113ne\u0161os sasniedza 5,4 milj. eiro, un, sal\u012bdzinot ar 2016. gada devi\u0146iem m\u0113ne\u0161iem, samazin\u0101j\u0101s par 0,05 milj. eiro vai par 1%.<\/p>\n\n\n\n
2017. gada devi\u0146os m\u0113ne\u0161os akt\u012bvo farmaceitisko vielu p\u0101rdo\u0161anas apjoms sasniedza 5,3 milj. eiro, kas ir par 0,6 milj. eiro vai 12% vair\u0101k nek\u0101 2016. gada devi\u0146os m\u0113ne\u0161os. \u0160aj\u0101 period\u0101 liel\u0101kais Grindeks akt\u012bvo farmaceitisko vielu eksports tikai veikts uz ES valst\u012bm, Kan\u0101du, Austr\u0101liju un Jap\u0101nu. Grindeks piepras\u012bt\u0101k\u0101s akt\u012bv\u0101s farmaceitisk\u0101s vielas 2017. gada devi\u0146os m\u0113ne\u0161os bija zopiklons, oksitoc\u012bns, pimobend\u0101ns, ftoraf\u016brs, ksilaz\u012bns un medetomid\u012bns.<\/p>\n\n\n\n
AS Grindeks valdes priek\u0161s\u0113d\u0113t\u0101js Juris Bundulis: \u201eGrindeks koncerns \u0161\u012b gada devi\u0146os m\u0113ne\u0161os ir uzr\u0101d\u012bjis noz\u012bm\u012bgu apgroz\u012bjuma k\u0101pumu. S\u012bvaj\u0101 farm\u0101cijas uz\u0146\u0113mumu konkurenc\u0113 esam sasniegu\u0161i iev\u0113rojamus rezult\u0101tus \u2013 veiktie ieguld\u012bjumi m\u0101rketinga un p\u0101rdo\u0161anas stiprin\u0101\u0161an\u0101 sevi ir attaisnoju\u0161i, uzr\u0101dot sekm\u012bgu atdevi un paverot jaunas p\u0101rdo\u0161anas iesp\u0113jas. Ar\u012b n\u0101kotn\u0113 galvenok\u0101rt koncentr\u0113simies uz eksporta pieauguma veicin\u0101\u0161anu un produktu portfe\u013ca att\u012bst\u012bbu.\u201d<\/em><\/p>\n","protected":false},"excerpt":{"rendered":" \u0160odien, 27. novembr\u012b, akciju sabiedr\u012bbas Grindeks \u201eNasdaq Riga\u201d iesniegtie 2017. gada devi\u0146u m\u0113ne\u0161u nerevid\u0113tie konsolid\u0113tie finan\u0161u p\u0101rskati liecina, ka koncerna apgroz\u012bjums 2017. gada devi\u0146os m\u0113ne\u0161os…<\/p>\n","protected":false},"author":3,"featured_media":2005,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-2008","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-jaunums"],"acf":[],"_links":{"self":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/2008","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/comments?post=2008"}],"version-history":[{"count":0,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/2008\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media\/2005"}],"wp:attachment":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media?parent=2008"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/categories?post=2008"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/tags?post=2008"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}